US Patent Issued to NEUROQUEST on March 17 for "Compositions, kits, and methods for detecting preclinical alzheimer's disease" (Australian, Israeli Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,578,344, issued on March 17, was assigned to NEUROQUEST LTD. (Misgav Business Park, Israel).

"Compositions, kits, and methods for detecting preclinical alzheimer's disease" was invented by Xin Huang (Mernda, Australia), Yihan Li (Parkville, Australia), James Doecke (Tamborine, Australia), Baijun Gu (Mernda, Australia) and Michal Eisenbach-Schwartz (Rehovot, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and kits for diagnosing and prognosing Alzheimer's Disease (AD) in a human patient include a binding agent such as a monoclonal antibody for a biomarker conjugated to a detectable moiety such as a fluorophore, wherein the biomarker i...